FOCAD/miR-491-5p, downregulated by EGR1, function as tumor suppressor by inhibiting the proliferation and migration of gastric cancer cells
Ruifang Sun(Xi'an Jiaotong University), Dangxia Zhou(Xi'an Jiaotong University), Mo‐qi Lv(Xi'an Jiaotong University), Xiang Yu(GSI Helmholtz Centre for Heavy Ion Research), Juan Zhang(University of Science and Technology of China), Yang Yang(University of Maryland, Baltimore), Zhigang Liu(Children's Hospital of Zhejiang University), Jian Zhang(Zhujiang Hospital), Caixia Ding(Shanxi Medical University), Qiuyu Jiang(China Agricultural University), Yun Lv(Shaanxi Provincial People's Hospital), Yanqi Yang(Shaanxi University of Chinese Medicine), Chang‐An Zhao(Xi'an Jiaotong University)
Cited by 6
Related Papers
NF-κB in biology and targeted therapy: new insights and translational implications
|Signal Transduction and Targeted Therapy|2024|1.6k
<i>TBX6</i> Null Variants and a Common Hypomorphic Allele in Congenital Scoliosis
|New England Journal of Medicine|2015|317
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
|Journal of Hematology & Oncology|2022|273
Preparation of Multifunctional Drug Carrier for Tumor-Specific Uptake and Enhanced Intracellular Delivery through the Conjugation of Weak Acid Labile Linker
|Bioconjugate Chemistry|2009|161
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis
|Journal of Experimental & Clinical Cancer Research|2021|160